Á. Gil-Martín

All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings

J. Losa, P. Ryan, C. Barros, 2018, Hepatology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2019, AIDS.

Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2018, AIDS.

Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2019, AIDS.